
Reinsurer Swiss Re issues longevity drug guidelines
Swiss Re's guidelines for underwriters are intended to be used to assess longevity drugs that show signs of being used. Keystone / Gaetan Bally Listen to the article Listening the article Toggle language selector Select your language Close English …